focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,163.00
Bid: 1,164.00
Ask: 1,166.00
Change: 2.00 (0.17%)
Spread: 2.00 (0.172%)
Open: 1,154.00
High: 1,168.00
Low: 1,149.00
Prev. Close: 1,161.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kiskadee update

19 Jan 2015 08:22

RNS Number : 4890C
Hiscox Ltd
19 January 2015
 



 

 

Hiscox announces strong inflows to the Kiskadee ILS Funds

 

 

Hamilton, Bermuda, (19 January, 2015) - Hiscox today announces that total assets under management in its Kiskadee insurance-linked strategies (ILS) funds, have grown to over $400 million at 1 January 2015. Commitments from existing investors have been complemented by strong inflows from new investors, and Kiskadee has also received firm commitments of additional capital for deployment between now and the summer 2015 reinsurance renewal season.

 

The Kiskadee Diversified Fund Ltd and Kiskadee Select Fund Ltd are actively managed open-ended Bermuda domiciled funds. The Kiskadee funds offer investors greater capital efficiency and market access than traditional direct collaterelised ILS funds through their alignment with Hiscox. This structure enables the construction of investible portfolios from a broad and more diverse universe of reinsurance and retrocession risks.

 

Jeremy Pinchin, CEO, Hiscox Re, commented "Our Kiskadee funds combine superior risk selection with diversified market access provided by the Hiscox Group. We believe this is a truly distinctive offering and so are pleased at the enthusiastic response from new and existing investors. Hiscox has a long history of managing alternative forms of capital. Kiskadee is a natural continuation of working with like-minded, long-term partners and offering enhanced solutions to our reinsurance clients."

 

Ends

 

For further information please contact:

Hiscox Ltd

Kylie O'Connor +44 (0) 20 7448 6656 Kylie.O'Connor@HISCOX.com

 

Brunswick

Tom Burns +44 (0) 20 7404 5959 TBurns@brunswickgroup.com 

 

Notes to editors

 

About Kiskadee

Kiskadee Investment Managers, a wholly owned subsidiary of specialist insurer Hiscox, provides investors with the access to the substantial insurance and reinsurance resources of the Hiscox Group. In addition to our flagship Kiskadee Diversified and Kiskadee Select Funds the investment management platform offers single investor funds and bespoke vehicles for tailored insurance, reinsurance portfolios and larger investment allocations.

 

 

About Hiscox

 

Hiscox, the international specialist insurer, is headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). There are three main underwriting divisions in the Group - Hiscox London Market, Hiscox Re and Hiscox Retail (which includes Hiscox UK and Europe, Hiscox Guernsey, Hiscox USA and subsidiary brand, DirectAsia). Hiscox underwrites internationally traded, bigger ticket business and reinsurance through Hiscox Re and Hiscox London Market. Through its retail businesses in the UK, Europe and the US Hiscox offers a range of specialist insurance for professionals and business customers, as well as homeowners. For further information, visit www.hiscoxgroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVKLBFEFFLBBF
Date   Source Headline
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSResult of AGM
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20241:11 pmRNSSyndicates 33 and 6104 - results and estimates
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:01 amRNSShare Repurchase Programme.
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSQ1 2024 Trading Statement
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20243:57 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202412:17 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20245:15 pmRNSAdditional Listing
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20244:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:16 pmRNSTotal Voting Rights
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202411:30 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20243:37 pmRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20242:06 pmRNSNotice of 2024 AGM and 2023 Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.